Jordan Budgen
-
ADHD, amphetamines, atomoxetine, bupropion, clonidine, dexmethylphenidate, guanfacine, medication, medication safety, medicines, meta-analysis, methylphenidate, modafinil, network meta-analysis, neurodiversity, pharmacological intervention, psychopharmacology, Stimulants, systematic review, The Lancet Psychiatry, therapeutic inertia, viloxazineThe Goldilocks zone: getting ADHD medication ‘just right’
Neurodivergence, including Attention Deficit-Hyperactivity Disorder (ADHD), remains an area of great interest…
